Honeywell HomMed Telemonitor
Devicetelemonitoring post hospitalization
NCT Number: NCT01393314
This is a randomized controlled trial of telemonitoring vs usual care provided by home care agencies for patients with heart failure.
The study hypothesis is that Telemonitoring will reduce hospital re-admission rates, urgent care visits, unscheduled physician appointments, Emergency Room visits in patients with heart failure over the 60 day post hospitalization period.
Looking for future studies?
Notify Me55 year and older
All sexes
Interventional
Not applicable
A 60 day stratified, randomized clinical trial of a home-based telemonitoring system (TEP) vs. usual home-care with educational package (EP). Both Groups will receive intensive patient education and primary care physicians will be prompted to adhere to heart failure management guidelines. The study will be conducted on 100 patients receiving home care nursing services post-hospital discharge.
Each participant will be randomized in equal amounts to treatment (TEP) or no treatment (EP).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
telemonitoring post hospitalization
Time frame: Participants were followed for the duration of home care services up to 12 months
Median time to combined endpoint to see if/when the participants need to be readmitted to the hospital or visit the ED
Time frame: Participants were followed for the duration of home care services up to 12 months
Health Status, Change in Overall Summary Score minimum: 0 maximum: 100 higher scores=better outcome
Case Western Reserve University
Other
A Randomized Controlled Trial of Telemonitoring in Older Adults With Heart Failure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02061319
Cardiovascular Diseases, Heart Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT06576050
Body Weight, Body Weight Changes
Boston, Massachusetts, United States
View Trial DetailsNCT04113109
Cardiovascular Diseases, Heart Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT05236673
Cardiovascular Diseases, Heart Diseases
Anyang-si, Gyeonggi-do, South Korea
View Trial Details